News
- Author:
- Elizabeth Mechcatie
Publish date: October 14, 2017
Approval was based on phase 3 data, according to the manufacturer.
Video
- Author:
- Elizabeth Mechcatie
Publish date: October 2, 2017
Nickel and balsam of Peru are among the more common causes of systemic contact dermatitis.
News
- Author:
- Elizabeth Mechcatie
Publish date: July 13, 2017
The approved indication is for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Article
- Author:
- Elizabeth Mechcatie
Publish date: May 25, 2017
Most of the women in the review improved with spironolactone, including those who had not responded to other therapies.
News
- Author:
- Elizabeth Mechcatie
Publish date: April 17, 2017
The first targeted biologic therapy approved for treating atopic dermatitis provides a welcome, long-awaited alternative to currently available the...
News
- Author:
- Elizabeth Mechcatie
Publish date: March 28, 2017
Approved for moderate to severe atopic dermatitis in adults for whom topical prescription therapies don’t work or are not appropriate.
Video
- Author:
- Elizabeth Mechcatie
Publish date: March 24, 2017
ORLANDO – The applications for picowavelength lasers have uses for cosmetic indications other than tattoo removal.
Video
- Author:
- Elizabeth Mechcatie
Publish date: March 24, 2017
ORLANDO – It may be time to start considering new options for treating keloids, according to Amy McMichael, MD, professor of dermatology at Wake Fo...
Video
- Author:
- Elizabeth Mechcatie
Publish date: March 5, 2017
ORLANDO – Criteria used to identify individuals at risk of hereditary melanoma who may be candidates for genetic testing may be modified soon.
News
- Author:
- Elizabeth Mechcatie
Publish date: February 27, 2017
Look for the latest news in medical, surgical, and aesthetic dermatology
News
- Author:
- Elizabeth Mechcatie
Publish date: February 24, 2017
WAILEA, HAWAII – Currently available treatments for reducing fat have permanent effects and don’t involve uncomfortable procedures.
News
- Author:
- Elizabeth Mechcatie
Publish date: February 16, 2017
The FDA has approved brodalumab for treating moderate to severe psoriasis, with a REMS that addresses a risk of suicidal ideation and behavior obse...
Article
- Author:
- Elizabeth Mechcatie
Publish date: December 1, 2016
A medical minerals exhibit currently on display at the National Institutes of Health Clinical Center includes several examples of minerals that are...
Article
- Author:
- Elizabeth Mechcatie
Publish date: November 10, 2016
LAS VEGAS – New topical treatment options for onychomycosis represent significant...
Article
- Author:
- Elizabeth Mechcatie
Publish date: November 5, 2016
Etanercept has been approved for treating children and adolescents, aged 4-17 years, with chronic moderate to severe plaque psoriasis.
